Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 7Triple Negative Breast Neoplasms 6Carcinoma, Non-Small-Cell Lung 4Small Cell Lung Carcinoma 3Neoplasm Metastasis 3Squamous Cell Carcinoma of Head and Neck 2Osteosarcoma 2Lung Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Sarcoma, Ewing 1Pathologic Complete Response 1Neutropenia 1Neoplasms 1NSCLC 1Myelosuppression 1Hemangiosarcoma 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Transitional Cell 1Advanced Squamous Non-Small-Cell Lung Cancer 1

Interventions

Temozolomide 10Cyclophosphamide 10Vincristine 9Etoposide 6Doxorubicin 6Irinotecan 5palbociclib 4cabozantinib 4Topotecan 4Melphalan 4Magnetic Resonance Spectroscopy 4X-Rays 3Sirolimus 3Phantoms, Imaging 3Ifosfamide 3Gemcitabine 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2olaparib 2ivosidenib 2irinotecan sucrosofate 2ganitumab 2cixutumumab 2Vemurafenib 2Trabectedin 2Tacrolimus 2Specimen Handling 2Peripheral Blood Stem Cell Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Sarcoma, Ewing × trilaciclib × Clear all
NCT06699472 2024-11-21

A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib

Fudan University

Phase 2 Recruiting
22 enrolled
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡